Hospitals & Diagnostics · Medical/Nursing Services · NSE: MAXIND · data 2026-10-31
Max India Ltd
In plain words
Price: 33.1% below its 52-week high of ₹220.
Delivery: 55.5% of traded shares were kept for delivery over the last 10 sessions, against 58.0% over the last 60.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹214 cr |
| Net profit (last 12 months) | ₹-132 cr |
| Sales growth, 3 years (yearly) | -1.1% |
| Profit growth, 3 years (yearly) | — |
At a glance
Promoters 48.2% (-1.8 pts in a year), pledged 0.0%, institutions 11.8%.
ROE -31.8%, ROCE -26.9%, operating margin -56.1%: how much profit it earns on the money it uses.
Debt/equity 0.24, Profit growth — and sales growth -1.1% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
None flagged by these rules.
- Low return on equity (-31.8%).
- Thin operating margin (-56.1%).
- Promoters cut their holding by 1.8 points in a year.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
5/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Delivery 43.6% over the last 20 sessions vs 60.8% in the 40 before (0.72x); shares delivered per day 0.63x usual; 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Rights
- 29 Apr 25Rights Rights issue 19:100 · premium ₹140 (ex-date) -15.8% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 48.22% | 49.77% | 49.82% | 49.89% |
| Foreign institutions (FII) | 6.89% | 7.06% | 7.07% | 7.08% |
| Domestic institutions (DII) | 4.94% | 1.66% | 1.63% | 1.58% |
| Mutual funds | 0.00% | 0.00% | 0.00% | 0.00% |
| Retail investors | 16.45% | 17.20% | 17.44% | 17.77% |
| Number of shareholders | 36,788 | 36,826 | 37,492 | 38,508 |
Common questions
How much do promoters hold in Max India Ltd?
Promoters held 48.22% of Max India Ltd at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Max India Ltd debt-free?
Its latest reported debt-to-equity ratio is 0.24.
What is the 52-week high and low of Max India Ltd?
The 52-week high is ₹220 and the 52-week low is ₹120.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Max India Ltd | ₹147.22 | ₹828 cr | — | — | -31.8% | -26.9% | 0.24 | -30.6% |
| Laxmi Dental Ltd. | ₹177.58 | ₹978 cr | 31.6 | — | 12.8% | 11.4% | 0.05 | -43.3% |
| Unihealth Hospitals Ltd | ₹550.25 | ₹875 cr | 33.1 | 6.3 | 21.4% | 22.7% | 0.24 | +221.8% |
| Gaudium IVF & Women Health Ltd. | ₹105.86 | ₹770 cr | — | — | 24.7% | 35% | 0.16 | +27.5% |
| CHANDAN HEALTHCARE LIMITED | ₹235 | ₹575 cr | — | — | 18.4% | 23.4% | 0.31 | -33.8% |
| Rays of Belief Limited | ₹245.16 | ₹513 cr | — | — | — | — | — | +2.6% |
Compare MAXIND with LAXMIDENTL in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open MAXIND in NSE Scanner →